UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$834M |
| 2 |
Alibaba
BABA
|
+$559M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$557M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$459M |
| 5 |
Stellantis
STLA
|
+$454M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$828M |
| 2 |
Apple
AAPL
|
+$800M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$654M |
| 4 |
Boeing
BA
|
+$592M |
| 5 |
JPMorgan Chase
JPM
|
+$416M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.37% |
| 2 | Healthcare | 6.89% |
| 3 | Financials | 5.79% |
| 4 | Consumer Discretionary | 5.66% |
| 5 | Communication Services | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
BioCryst Pharmaceuticals
BCRX
$2.4B
| $10.2M | ﹤0.01% |
5,083,238
-405,049
| -7% | -$1.12M |
|
1402
PUT
Estee Lauder
EL
$32B
| $10.2M | ﹤0.01% |
63,700
-21,500
| -25% | -$4.15M |
|
|
TCO
1403
DELISTED
Taubman Centers Inc.
TCO
| $10.1M | ﹤0.01% |
242,032
+102,806
| +74% | +$4.28M |
|
1404
iShares Global Comm Services ETF
IXP
$572M
| $10.1M | ﹤0.01% |
195,414
+140,251
| +254% | +$8.31M |
|
1405
CALL
Ulta Beauty
ULTA
$24.3B
| $10.1M | ﹤0.01% |
57,500
+5,000
| +10% | +$1.25M |
|
1406
PUT
Under Armour
UAA
$2.6B
| $10.1M | ﹤0.01% |
1,095,000
+795,000
| +265% | +$12.8M |
|
1407
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.51B
| $10.1M | ﹤0.01% |
555,888
-76,565
| -12% | -$1.58M |
|
1408
CALL
TJX Companies
TJX
$178B
| $10.1M | ﹤0.01% |
210,800
+18,100
| +9% | +$1.04M |
|
1409
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
$2.09B
| $10.1M | ﹤0.01% |
412,329
+198,090
| +92% | +$5.77M |
|
1410
Federal Realty Investment Trust
FRT
$10.3B
| $10M | ﹤0.01% |
134,661
-100,824
| -43% | -$11.6M |
|
1411
Elanco Animal Health
ELAN
$11.1B
| $10M | ﹤0.01% |
448,103
-183,090
| -29% | -$5.01M |
|
1412
CALL
PG&E
PCG
$38.5B
| $10M | ﹤0.01% |
1,112,900
+801,000
| +257% | +$10.6M |
|
1413
BioMarin Pharmaceuticals
BMRN
$12.4B
| $9.97M | ﹤0.01% |
117,973
-26,296
| -18% | -$2.27M |
|
1414
CALL
Franco-Nevada
FNV
$46B
| $9.95M | ﹤0.01% |
100,000
| – | – |
|
|
HIX
1415
Western Asset High Income Fund II
HIX
$355M
| $9.93M | ﹤0.01% |
1,982,951
-3,159,978
| -61% | -$19.9M |
|
1416
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$586M
| $9.93M | ﹤0.01% |
420,701
-95,756
| -19% | -$2.8M |
|
1417
CALL
RH
RH
$3.71B
| $9.93M | ﹤0.01% |
98,800
-54,000
| -35% | -$10.1M |
|
|
PRAH
1418
DELISTED
PRA Health Sciences, Inc.
PRAH
| $9.91M | ﹤0.01% |
119,308
+17,740
| +17% | +$1.73M |
|
1419
VeriSign
VRSN
$26.6B
| $9.9M | ﹤0.01% |
54,977
-89,859
| -62% | -$17.7M |
|
1420
PUT
Marathon Petroleum
MPC
$83.7B
| $9.9M | ﹤0.01% |
419,000
-564,200
| -57% | -$26M |
|
1421
CALL
Amgen
AMGN
$222B
| $9.89M | ﹤0.01% |
48,800
-32,600
| -40% | -$7.12M |
|
1422
CALL
Trip.com Group
TCOM
$29.1B
| $9.87M | ﹤0.01% |
420,700
+245,700
| +140% | +$7.66M |
|
|
VER
1423
DELISTED
VEREIT, Inc.
VER
| $9.79M | ﹤0.01% |
400,614
-199,488
| -33% | -$8.43M |
|
|
1424
PUT
TJX Companies
TJX
$178B
| $9.79M | ﹤0.01% |
204,800
+43,700
| +27% | +$2.51M |
|
1425
Invesco BuyBack Achievers ETF
PKW
$1.76B
| $9.79M | ﹤0.01% |
202,043
-88,426
| -30% | -$5.49M |
|
Similar funds
UBS Group's Q1 2020 Portfolio in Review
As of Q1 2020, UBS Group held 8,948 positions worth $212B, down 26% from $287B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
UBS Group withdrew a net $21.6B in Q1 2020, closing 880 positions and reducing 4,775 holdings. Its most notable exit was Wellcare Health Plans, Inc., an estimated $196M position sold in full.
By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.8% a quarter earlier, followed by Healthcare and Financials.
Against the trend, UBS Group opened a new position in VelocityShares Daily 2x VIX Short Term ETN worth $221M.
- UBS Group's largest Q1 2020 buy was VelocityShares Daily 2x VIX Short Term ETN: 705,722 shares worth $221M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $834M increase.
- UBS Group's biggest Q1 2020 reduction was Microsoft, cutting an estimated $828M.
- UBS Group fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $196M.
- UBS Group's ten largest holdings make up 17% of its $212B portfolio in Q1 2020.
- UBS Group opened 748 new positions and closed 880 in Q1 2020.
- UBS Group's portfolio value fell 26% quarter-over-quarter to $212B.
Based on UBS Group's 13F filing for Q1 2020, filed 1 May 2020.